Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
News
20 Nov 2024
Over half of Americans won't get the new COVID-19 vaccine
Although over half of Americans do not plan to get the new COVID-19 vaccine for a range of reasons, perceptions vary based on political affiliation, age and race. Continue Reading
-
Feature
14 Nov 2024
Employing ML to boost pharmacokinetics in drug development
Machine learning revolutionizes pharmacokinetics by accurately predicting drug behavior and optimizing dosages, streamlining drug development and regulatory approval. Continue Reading
-
Feature
07 Sep 2022
How Chemotherapy Drugs Impact Cells, Patients, and the Healthcare System
Chemotherapy drugs have multiple impacts, including slowing cell proliferation, improving patient outcomes, and stressing the healthcare system. Continue Reading
-
News
06 Sep 2022
FDA Announces That 35% of Drug Samples Were Non-Compliant
The FDA’s Report on The State of Pharmaceutical Quality announced that, in the 2021 fiscal year, the number of non-compliant drug samples increased to 35%, over twice as much as the 2020 fiscal year (FY). Continue Reading
-
Feature
30 Aug 2022
Understanding the Burdens of Dialysis
For patients with chronic kidney disease that progresses into end-stage renal failure, dialysis is an additional burden that impacts lifestyle and financial security. Continue Reading
-
News
24 Aug 2022
Judge Rules against CVS, Walgreens, and Walmart in Ohio Opioid Case
In an Ohio opioid court case, a federal judge ruled against CVS, Walgreens, and Walmart pharmacies, ordering them to pay $650.5 million to two Ohio counties. Continue Reading
-
Feature
23 Aug 2022
A History of Insulin Development and Insulin Delivery Systems
In recent years, insulin has caught media attention due to its increasing costs; understanding the basics of insulin and delivery systems can help us better understand how to address the prices. Continue Reading
-
News
19 Aug 2022
CVS Implements Time Delay Safes for Controlled Substances
A recent statement by CVS Health announced that they are implementing time delay safes for controlled substances. Continue Reading
-
News
18 Aug 2022
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
A routine inspection of Merck’s popular diabetes drug — Januvia — detected nitrosamine, a possible human carcinogen. Continue Reading
-
News
18 Aug 2022
California Allots $100 Million to Produce Insulin, Improving Access
The state of California recently announced that it would allot approximately $100 million to the production of insulin biosimilars to improve insulin access. Continue Reading
-
Feature
16 Aug 2022
How Pharmaceutical Patents Contribute to Increased Drug Costs
Patents in the pharmaceutical industry contribute to increased drug costs and create barriers to healthcare accessibility. Continue Reading
-
Feature
10 Aug 2022
A History of Antivirals: Mechanisms, Classes, and Subtypes
Understanding the history, mechanisms, classes, and subtypes of antivirals may help inform the development and distribution of such drugs. Continue Reading
-
News
03 Aug 2022
$4.25 Billion Opioid Settlement by Teva Pharmaceuticals
Teva Pharmaceuticals — one of the biggest opioid producers in the world — has reached a tentative $4.25 billion opioid settlement. Continue Reading
-
Feature
02 Aug 2022
Limited Access to Female Contraceptives: A Public Health Crisis
Limited access and understanding of female contraceptives have posed a threat to women, causing a public health crisis. Continue Reading
-
Answer
25 Jul 2022
A New Liver Disease Diagnostic and Prevention Approach
A new software developed by Oncoustics may improve liver disease diagnosis and prevention. Continue Reading
-
News
21 Jul 2022
Depression, Anxiety Prescriptions Soar During Coronavirus Pandemic
A household survey conducted during the first two years of the coronavirus pandemic found a large increase in the number of mental health medications Americans were prescribed. Continue Reading
-
Feature
19 Jul 2022
How Pharmaceutical Companies Have Exacerbated the Opioid Epidemic
Drug use, specifically the opioid epidemic, has been an ever-present public health crisis exacerbated by pharmaceutical companies in the United States since the late 1900s. Continue Reading
-
Feature
11 Jul 2022
Revolutions in Neuroscience: Deep Brain Stimulation
Deep brain stimulation is a major revolution in neuroscience that has provided additional options for treatment-resistant neurological disorders. Continue Reading
-
News
27 Jun 2022
Epilepsy Drug Prices Have Increased by 277% in the Past Decade
A recent statement from the American Academy of Neurology found that brand-name epilepsy drug prices have increased by 277% in the past decade. Continue Reading
-
News
27 Jun 2022
How Data, Apps, and Hackers Are Reshaping Healthcare
Data, apps, and hackers are reshaping healthcare by leveraging innovative digital solutions and strategic partnerships, shifting the focus from providers to patients. Continue Reading
-
News
21 Jun 2022
Beta Bionics Shares Clinical Trial Data on Bionic Pancreas for Type 1 Diabetes
Beta Bionics presented clinical trial data on an insulin-only Bionic Pancreas for type 1 diabetes at the American Diabetes Association Scientific Sessions. Continue Reading
-
News
14 Jun 2022
Eli Lilly Sued by Whistleblower for Pharmaceutical Manufacturing Issue
Drugmaker Eli Lilly terminated whistleblower Amrit Mula after she identified pharmaceutical manufacturing irregularities involving Trulicity — the company’s popular biologic diabetes medication. Continue Reading
-
News
23 May 2022
FDA Amends EUA For Pfizer-BioNTech’s COVID-19 Vaccine Booster
In other COVID news, AstraZeneca enters an agreement to develop COVID-19 antibodies and Novavax files for emergency use authorization of its COVID-19 vaccine in Taiwan. Continue Reading
-
News
20 May 2022
Prescription Drug Manufacturer Pre-Rebate Costs Skyrocket
Median prescription drug manufacturer pre-rebate costs per covered life increased by 54.5% for individual plans, 24% for small group plans, and 7.6% for large group plans annually. Continue Reading
-
News
18 May 2022
FDA Approves Eli Lilly and Company’s Type 2 Diabetes Injectable
In five clinical trials that evaluated three different doses of Eli Lilly’s Mounjaro, the drug improved blood sugar and was more effective than other types of 2 diabetes therapies. Continue Reading
-
News
17 May 2022
Roche, Global Fund to Build Diagnostic Capacity of HIV, Tuberculosis
Roche’s Global Access Program, The Global Fund to Fight AIDS, and Tuberculosis and Malaria partner to improve the diagnosis of HIV and TB in low-and-middle-income countries. Continue Reading
-
News
17 May 2022
J&J Appoints Thibaut Mongon CEO of New Consumer Health Company
The planned consumer health company would create two global leaders better positioned to deliver improved health outcomes for patients and consumers. Continue Reading
-
News
16 May 2022
Janssen Pharmaceuticals Terminates Collaboration in Hepatitis B, HPV
Janssen will prioritize the investigation of its hepatitis B combination therapies using alternative investigational vaccine platforms and therapeutics within its broad portfolio. Continue Reading
-
News
13 May 2022
FDA Limits Use of Johnson & Johnson COVID-19 Vaccine
In other COVID news, FDA approves Eli Lilly's COVID-19 treatment and Novavax submits variations to expand its vaccine approval in Australia and New Zealand. Continue Reading
-
News
11 May 2022
Pfizer’s COVID-19 Treatment Reduces Disease by 37% Post-Exposure
In other COVID news, GSK submits a biologics license application for its COVID-19 vaccine and Novavax requests to expand its vaccine authorization in Great Britain. Continue Reading
-
News
05 May 2022
AstraZeneca to Open Drug Research, Development Site in MA
The strategic center will bring nearly 1,500 drug research and development, commercial, and corporate colleagues into a single purpose-built space in Cambridge, MA. Continue Reading
-
News
04 May 2022
Dr. Vishal Sikka to Join GSK as Non-Executive Director
Dr. Vishal Sikka joins GSK's board as non-executive director from the Haleon demerger and a board member of Oracle Corporation and BMW. Continue Reading
-
News
04 May 2022
FDA Expands Approval of COVID-19 Treatment, Remdesivir
In other COVID news, Moderna submits an emergency use authorization request for its COVID-19 vaccine and Novavax initiates administration of the first booster dose of its vaccine. Continue Reading
-
News
02 May 2022
J&J Launches Satellite Center to Tackle Antimicrobial Resistance
J&J’s Satellite Center in Cape Town, South Africa, will bolster early-stage science, innovation, and talent development to tackle antimicrobial resistance and other global health issues. Continue Reading
-
News
28 Apr 2022
Moderna Appoints Arpa Garay as Chief Commercial Officer
Moderna recently announced that Arpa Garay will join the company as chief commercial officer, effective May 31, 2022. Continue Reading
-
News
26 Apr 2022
FDA Considers New Strategy to Boost Safe Opioid Disposal
The modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy would provide a convenient disposal option for patients beyond those already available. Continue Reading
-
News
26 Apr 2022
GSK Enters $1.9B Agreement to Develop Rare Cancer Treatments
GSK will acquire Sierra Oncology and its inhibitor, momelotinib, which addresses the critical unmet needs of patients with rare cancer myelofibrosis. Continue Reading
-
News
25 Apr 2022
FDA Issues EUA to First COVID-19 Test Using Breath Samples
In other COVID news, Pfizer, BioNTech's COVID-19 vaccine is positive in a Phase 2/3 trial and Moderna announces positive data on its bivalent COVID-19 booster platform. Continue Reading
-
News
19 Apr 2022
WHO Recommends Johnson & Johnson’s COVID-19 Vaccine for Booster Use
In other COVID news, FDA grants priority review to Roche’s COVID-19 treatment and Thermo Fisher Scientific wins an award for expediting COVID-19 vaccine approvals during the pandemic. Continue Reading
-
News
18 Apr 2022
Sanofi Launches First-in-Pharma Diversity, Equity, Inclusion Board
The first-in-pharma board focuses on building leadership and creating a work environment where employees can bring their whole selves and engage with Sanofi’s diverse communities. Continue Reading
-
News
15 Apr 2022
FDA Issues Draft Guidance to Increase Clinical Trial Diversity
The FDA guidance focuses on enhancing clinical trial diversity for medical products, aligning with the Biden Administration’s Cancer Moonshot goal to address inequities and beyond. Continue Reading
-
News
12 Apr 2022
FDA Approves ViiV Healthcare’s HIV-1 Treatment for Children
Other FDA approvals include Kite’s large B-cell lymphoma therapy, Yescarta, and Novartis’ drug for PIK3CA-Related Overgrowth Spectrum (PROS). Continue Reading
-
News
11 Apr 2022
Pfizer Appoints David M. Denton as CFO, Executive Vice President
As Moderna's CFO, Denton will be a key thought partner to the company's CEO and executive leadership team and be responsible for all corporate finance functions. Continue Reading
-
News
11 Apr 2022
Merck Expands Broad Access to HPV Vaccines Globally
Merck will expand its vaccines manufacturing facility in Virginia to 120,000 square feet and add 150 new jobs to increase the capacity and supply of its HPV vaccines. Continue Reading
-
News
07 Apr 2022
Moderna Launches Foundation to Promote Access to Quality Care
The program will support local and global communities impacted by COVID-19, advance scientific innovation, promote access to quality care, and advocate for inclusion and diversity. Continue Reading
-
News
06 Apr 2022
FDA Expands Indication of Long-Acting Injectable HIV Treatment
Other recent FDA approvals include Novo Nordisk’s type 2 diabetes drug and a seizure treatment for patients two years of age and older. Continue Reading
-
News
05 Apr 2022
Gilead Grants $24M to Improve Access, Care for HIV Communities
The Zeroing In initiative builds on Gilead’s previous funding and grant programs while increasing the health and wellbeing of communities most impacted by HIV and COVID-19. Continue Reading
-
News
31 Mar 2022
FDA Approves Second Dose of Moderna's COVID-19 Vaccine
In other recent COVID news, FDA expands the EUA for Pfizer and BioNTech's COVID-19 vaccine and Novavax announces the inclusion of its vaccine in two booster trials. Continue Reading
-
News
31 Mar 2022
FDA Declines Eli Lilly’s Letter for Non-Small Cell Lung Cancer Drug
FDA stated that it is unable to approve Eli Lilly’s application for its non-small cell lung cancer drug in its current form and recommended an additional multiregional clinical trial. Continue Reading
-
News
30 Mar 2022
FDA Approves Bristol Myers Antibody Combination for Melanoma
Other recent FDA approvals include Novartis’ prostate cancer drug and a second indication for Merck’s Keytruda for advanced endometrial carcinoma. Continue Reading
-
News
30 Mar 2022
J&J’s Global Initiatives Improve Disease Detection, Broaden Access
The initiatives will support global efforts to help find the millions of individuals living with undiagnosed tuberculosis and are part of J&J’s initiative to improve disease detection. Continue Reading
-
News
23 Mar 2022
Novavax Launches 2 Global Vaccine Programs As Educational Tools
The global vaccine programs, 'We Do Vaccines' and 'Know Our Vax,' will help provide educational information about how vaccines work and Novavax's overall global approach. Continue Reading
-
News
16 Mar 2022
Pfizer Initiates Phase 2/3 Clinical Trial of COVID-19 Treatment
In other COVID news, South African-based Aspen will manufacture J&J’s COVID-19 vaccine and Thermo Fisher’s viral inactivation for COVID sample transport is now available in Europe. Continue Reading
-
News
15 Mar 2022
FDA Approves Boehringer Ingelheim's Heart Failure Treatment
Other recent FDA approvals include Johnson & Johnson's multiple myeloma treatment and an expanded indication for Abbott's heart failure device. Continue Reading
-
News
15 Mar 2022
Moderna Launches Public Health Strategy to Advance mRNA Vaccines
Moderna will advance mRNA vaccines that address current infectious diseases in low- and middle-income countries through four global public health strategy initiatives. Continue Reading
-
News
11 Mar 2022
AMA Supports Biden's Medicare Proposal, Prescription Drug Policies
The AMA supports President Biden's proposal to reduce prescription drug costs for Medicare patients by including all pharmacy price concessions in the definition of "negotiated price." Continue Reading
-
News
10 Mar 2022
FDA Issues 3 Cancer Clinical Trial Final Guidance Documents
The clinical trial guidance documents parallel President Biden’s efforts to reduce the cancer death rate by at least 50% over the next 25 years, improve the experience of people living with cancer, and end cancer. Continue Reading
-
News
10 Mar 2022
Boehringer Ingelheim, Lifebit Partner to Advance Biomedical Data
The companies will leverage Lifebit’s secure CloudOS platform to build scalable analytics and infrastructure platform to emphasize the value of biomedical data. Continue Reading
-
News
09 Mar 2022
FDA Rejects Gilead’s Drug Application for HIV-1 Treatment
In its complete response letter, FDA cited Chemistry Manufacturing and Controls (CMC) issues relating to the compatibility of Gilead’s HIV-1 treatment, lenacapavir. Continue Reading
-
News
07 Mar 2022
UC Berkeley Loses CRISPR Gene-Editing Patent Appeal
After an eight-year-long legal battle over the commercial application of CRISPR gene editing, PTAB’s decision rocked UC Berkeley and biotech companies that originally licensed the technology. Continue Reading
-
News
03 Mar 2022
FDA Accepts Bristol Myers’s BLA for Non-Small Cell Lung Cancer Drug
FDA based its decision on Phase 3 trial results, which showed that the non-small cell lung cancer drug plus chemotherapy improved complete response and event-free survival in patients. Continue Reading
-
News
03 Mar 2022
FDA Accepts Application for Pfizer’s Biosimilar to Humira
A study of the interchangeable biosimilar Abrilada met its primary goal of pharmacokinetic equivalence in patients who switched between treatment with Abrilada and Humira. Continue Reading
-
News
02 Mar 2022
Nearly Half of All Medicare Drug Prices Increased From 2019-2020
Among the 1,947 Medicare-covered drugs with price increases above the inflation rate in 2020, one-third saw price increases of 7.5 percent or more, the current annual inflation rate. Continue Reading
-
News
28 Feb 2022
GSK Introduces Standalone Consumer Healthcare Company, Haleon
GSK and Pfizer proposed to combine their consumer healthcare business into a world-leading joint venture in 2019. Now, the companies will deploy Haleon in over 100 markets globally. Continue Reading
-
News
25 Feb 2022
Top-Selling Medicare Part D Prescription Drugs in Recent Years
Prescription drugs were not covered for Medicare beneficiaries before 2006. Now, the top-selling Medicare Part D drugs of all time include Revlimid, Eliquis, Xarelto, Trulicity, and Humira. Continue Reading
-
News
24 Feb 2022
GSK, Sanofi Seek Approval of COVID-19 Vaccine for Adults
In other COVID news, Novavax announces the first shipments of COVID-19 vaccine to EU member states and Australia grants provisional registration to Moderna’s vaccine. Continue Reading
-
News
24 Feb 2022
Lilly Launches Campaign to Educate Early Breast Cancer Patients
The collaboration campaign provides educational materials and other resources for individuals with certain types of breast cancers and their care partners. Continue Reading
-
News
22 Feb 2022
FDA Grants Emergency Authorization For Eli Lilly’s COVID-19 Antibody
In other COVID news, WHO grants Roche’s Actemra prequalification for COVID-19 in adults and Gilead’s COVID-19 treatment was well tolerated in pediatric patients. Continue Reading
-
News
17 Feb 2022
Bristol Myers Grants $7.9M to Improve Access to Care Across US
The health equity grants will increase access to care and support diversity, cultural competency, and collaboration among community health workers across the US. Continue Reading
-
News
17 Feb 2022
Gilead’s COVID-19 Treatment Effective Against Variants of Concern
In other COVID news, Moderna supplies 10.8-million doses of its COVID-19 vaccine to Colombia and the Siemens Healthineers COVID-19 antigen self-test is now available in the US. Continue Reading
-
News
15 Feb 2022
Senate Confirms Robert Califf as FDA Commissioner
The Senate narrowly confirms Robert Califf as FDA Commissioner after the Biden Administration’s nearly ten month-long battle to nominate him. Continue Reading
-
News
10 Feb 2022
Samsung Biologics to Accelerate Growth in Biosimilar Research
Samsung Biologics will acquire full ownership of Samsung Bioepis to further its streamlined operational efficiencies and boost its biosimilar and therapeutic research growth. Continue Reading
-
News
09 Feb 2022
Pfizer Seeks to Amend EUA of COVID-19 Vaccine to Include Children
The expanded authorization would include the first two COVID-19 vaccine doses of a planned three-dose primary series in children six months to four years old. Continue Reading
-
News
09 Feb 2022
FDA Approves Takeda’s Von Willebrand Disease Treatment
Other recent FDA Approvals include a T-cell receptor for adults with unresectable or metastatic uveal melanoma and insomnia treatment. Continue Reading
-
News
07 Feb 2022
CHMP Issues Positive Opinion of Pfizer’s COVID-19 Treatment
In other COVID news, Novavax and Israel entered into an agreement to supply Novavax’s COVID-19 vaccine in Israel and Daiichi Sankyo initiates a trial to study its vaccine booster in Japan. Continue Reading
-
News
03 Feb 2022
Patient, Prescription-Related Factors Linked to Opioid Overdose
The JAMA study found that patient and prescription-related factors can help guide clinicians during a patient’s opioid overdose experience. Continue Reading
-
News
03 Feb 2022
FDA Approves Label Update for CAR-T Cell Therapy, Yescarta
Yescarta is now the first and only chimeric antigen receptor (CAR) T-cell therapy with information on the label to help treat patients with large B-cell lymphoma. Continue Reading
-
News
02 Feb 2022
Former Head of Pharmaceutical R&D of Roche Joins Pfizer
William Pao will oversee Pfizer’s global product development organization and be responsible for the clinical development and advancement of the company’s pipeline. Continue Reading
-
News
02 Feb 2022
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine
In other COVID news, Novavax submits an emergency use authorization request to FDA for its COVID-19 vaccine and Merck’s COVID-19 treatment is proven effective against Omicron. Continue Reading
-
News
01 Feb 2022
Eli Lilly Invests $1B in Facility to Boost Access to Medicine in NC
The facility will utilize the latest technology to manufacture Eli Lilly and Company’s injectable products to increase access to medicine in North Carolina. Continue Reading
-
News
31 Jan 2022
Regeneron Gets FDA Review for Non-Small Cell Lung Cancer Treatment
Regeneron’s non-small cell lung cancer treatment, Libtayo, is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T-cells. Continue Reading
-
News
28 Jan 2022
2020 Drug Price Increase Driven by Generic Drugs, Biosimilars
The Vizient 2022 Pharmacy Market Outlook found that the overall estimated drug price inflation rate will be 3.09% due to high-cost medications, generic drugs to market, and biosimilars. Continue Reading
-
News
27 Jan 2022
FDA Expedites Approval of Gilead’s COVID-19 Treatment, Remdesivir
In other COVID news, FDA revises the authorization for two monoclonal antibody treatments and Pfizer initiates a clinical trial to study a new Omicron-based vaccine candidate. Continue Reading
-
News
27 Jan 2022
FDA Grants Clearance to Biotricity’s Arrhythmia Monitoring Device
The device addresses the current limitation of existing Holter monitors and creates a revenue stream with a simplified workflow to lower turnaround time and risk for patients and providers. Continue Reading
-
News
25 Jan 2022
Pharmacists’ Role to Expand to Direct Patient Care by 2030
Pharmacists’ role will continue to evolve over the next decade despite the shortage of doctors and nurses and as complex new therapies are developed. Continue Reading
-
News
24 Jan 2022
Cosette Acquires 8 Prescription Medications from Daiichi Sankyo
The transaction adds eight prescription medications focused on cardiovascular indications to Cosette Pharma’s current portfolio of over 45 commercial products. Continue Reading
-
News
21 Jan 2022
Pfizer’s COVID-19 Treatment Shows In Vitro Efficacy Against Omicron
In other COVID news, Merck and UNICEF expand access to its COVID-19 treatment to low- and middle-income countries and Australia grants provisional registration for Novavax’s vaccine. Continue Reading
-
News
19 Jan 2022
Tony Wood Replaces Hal Barron as GSK’s Chief Executive Officer
As chief executive officer of GSK, Wood will assume full responsibility for research and development across the company’s portfolio and pipeline from August 2022. Continue Reading
-
News
18 Jan 2022
Pfizer’s COVID-19 Vaccine, Pneumococcal Vaccine Helps Older Adults
Pfizer recently announced positive top-line results from a Phase 3 trial studying its COVID-19 vaccine combined with its pneumococcal 20-valent conjugate vaccine, Prevnar 20. Continue Reading
-
News
07 Jan 2022
Big Pharma Cooperation Advances Digital Measures, Drug Development
Industry cooperation to boost digital measures and focus on a more “patient-first” approach helps bring effective drugs to market for patients more quickly. Continue Reading
-
News
06 Jan 2022
FDA Expands MRI Compatibility for XR Spinal Cord Stimulation
FDA’s new labeling lifts MRI restrictions for lead tip locations and radiofrequency power used as part of the standard operating mode of an MRI scan. Continue Reading
-
News
06 Jan 2022
FDA Authorizes Siemens Healthineers COVID-19 Antigen Self-Test
In a recent study, the CLINITEST Rapid COVID-19 Antigen Self-Test demonstrated sensitivity of 86.5% and a specificity of 99.3% compared to the PCR detection method. Continue Reading
-
News
05 Jan 2022
FDA Approves Two Pediatric Indications For J&J’s Xarelto
Xarelto now has 11 indications in the US, the most of any direct oral anticoagulant (DOAC), and is the most studied oral FactorXa inhibitor in its class. Continue Reading
-
News
05 Jan 2022
iQ Group Seeks Approval for Diabetes Care Management Biosensor
The real-time biosensor is a small, organic, thin-film transistor diagnostic test that detects accurate salivary glucose measurement for diabetes care management. Continue Reading
-
News
04 Jan 2022
FDA Expands Authorization for Pfizer’s COVID-19 Vaccine Booster
FDA amended the authorization for the COVID-19 vaccine booster to include children 12 and older two months after expanding the authorization to include individuals 18 years and older. Continue Reading
-
News
03 Jan 2022
Biogen to Reduce Price of Alzheimer’s Disease Treatment by 50%
For a patient of average weight, the annual cost at the maintenance dose of the Alzheimer’s disease treatment will be $28,200. Continue Reading
-
News
30 Dec 2021
FDA Sends Warning Letter to Medtronic About Diabetes Business
The warning letter focused on the inadequacy of the requirements in risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events. Continue Reading
-
News
29 Dec 2021
FDA Issues Emergency Authorization for Merck’s COVID-19 Treatment
In a Phase 3 trial, 6.8% of patients who received molnupiravir were hospitalized or died before the 29-day follow-up, compared to 9.7% of patients who received placebo. Continue Reading
-
News
28 Dec 2021
Pharma Execs Site Supply Chain Visibility To Boost Manufacturing
Enhancing supply chain visibility can alleviate product loss and security concerns, boost quality assurance, replace outdated IT systems, and lower costs. Continue Reading
-
News
27 Dec 2021
Pfizer to Amend Clinical Study of COVID-19 Vaccine in Children
In other COVID news, AstraZeneca’s COVID-19 antibody neutralizes Omicron variant and the European Commission approved GSK’s COVID-19 antibody. Continue Reading
-
News
23 Dec 2021
FDA Approves ViiV Healthcare’s Long-Acting Injectable for HIV
In addition to ViiV’s long-acting injectable to treat HIV, recent FDA approvals include a myasthenia gravis treatment and AstraZeneca and Amgen’s asthma treatment. Continue Reading
-
News
22 Dec 2021
FDA Approves Pfizer’s Drug to Treat Adult Patients With AS
FDA approves Pfizer’s tofacitinib for AS patients. The drug is the first and only oral JAK inhibitor approved in the US for five indications. Continue Reading